Questions were raised over astrazeneca trial results. The ceo telling bloomberg within the last few minutes that it will now likely as a result run a new global trial, saying, now that we have found what looks like a better efficacy, we are going to have to validate this, and we need to do an additional study. It looks like it is going to be half of those full dose that could produce a higher efficacy then maybe a full dose. Europe and the United States continued to struggle with containing the virus resurgence. Germany is seeing a record increase in new cases, while new york cases are approaching 7000, hospitalizations hit their highest since june. Here was more is bloombergs, china here with more is bluebirds emma chandra here with more is bloombergs emma chandra. Emma astrazeneca are going to look to have a no other global trial to test the efficacy of the half dose, which they think will be better, and getting some more troubling figures out of large economies. The likes of new yor